---
figid: PMC7846853__CMAR-13-677-g0002
figlink: pmc/articles/PMC7846853/figure/f0001/
number: F1
caption: The PI3K pathway in the context of BCR signaling along with various targets.
  The BCR pathway is activated through antigen binding followed by recruitment and
  stimulation of LYN/SYK, resulting in phosphorylation of tyrosine residues on adapter
  proteins on the BCR as well as CD19. This enables the docking of PI3K regulator
  subunit to the BCR and CD19 and activation of the PI3K pathway. Activated PI3K phosphorylates
  PIP2 into PIP3 which stimulates PH domain signaling molecules including Akt. LYN/SYK
  also activate the BTK pathway which instigates PLCγ2 activation. The result of these
  processes is intranuclear transcriptional activation promoting cell survival. PTEN
  is a prominent negative regulator of this pathway. Also shown is the role of follicular
  T-helper cells and the PD-1/PDL-1 pathway. Created with BioRender.com.
pmcid: PMC7846853
papertitle: 'Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility
  and Experience from the Clinic.'
reftext: Ayushi F Chauhan, et al. Cancer Manag Res. 2021;13:677-692.
pmc_ranked_result_index: '23394'
pathway_score: 0.9183551
filename: CMAR-13-677-g0002.jpg
figtitle: PI3K pathway in the context of BCR signaling along with various targets
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7846853__CMAR-13-677-g0002.html
  '@type': Dataset
  description: The PI3K pathway in the context of BCR signaling along with various
    targets. The BCR pathway is activated through antigen binding followed by recruitment
    and stimulation of LYN/SYK, resulting in phosphorylation of tyrosine residues
    on adapter proteins on the BCR as well as CD19. This enables the docking of PI3K
    regulator subunit to the BCR and CD19 and activation of the PI3K pathway. Activated
    PI3K phosphorylates PIP2 into PIP3 which stimulates PH domain signaling molecules
    including Akt. LYN/SYK also activate the BTK pathway which instigates PLCγ2 activation.
    The result of these processes is intranuclear transcriptional activation promoting
    cell survival. PTEN is a prominent negative regulator of this pathway. Also shown
    is the role of follicular T-helper cells and the PD-1/PDL-1 pathway. Created with
    BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - IL10
  - CD19
  - PDCD1
  - CD274
  - CD79A
  - CD79B
  - SYK
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MYD88
  - LYN
  - STAT3
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT4
  - STAT5B
  - NFATC1
  - PLP2
  - BTK
  - PTEN
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - IKBKG
  - PLCG1
  - PLCG2
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - Fostamatinib
  - Ibrutinib
genes:
- word: °BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: CD19
  symbol: CD19
  source: hgnc_symbol
  hgnc_symbol: CD19
  entrez: '930'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: CD79a/b
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: CD79a/b
  symbol: CD79B
  source: hgnc_symbol
  hgnc_symbol: CD79B
  entrez: '974'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: NFATC1
  symbol: NFATC1
  source: hgnc_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Fostamatinib
  source: MESH
  identifier: C523665
- word: Ibrutinib
  source: MESH
  identifier: C551803
diseases: []
figid_alias: PMC7846853__F1
redirect_from: /figures/PMC7846853__F1
figtype: Figure
---
